DRD1 and Cognitive impairment: An improved understanding of the dopamine D1 receptor role in CIAS has led to the development of other compounds to optimize the beneficial effects of dopamine D1 receptor stimulation in the prefrontal cortex to ameliorate cognitive deficits in patients with CIAS [5].